The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Cell Therapy Discovery & Innovation, which will build upon longstanding MD Anderson clinical and ...
has expanded its reach by acquiring a 50% equity interest in MSO Metro, LLC, enhancing their management of 50 outpatient physical therapy clinics, mainly in New York. This strategic acquisition ...
New strategic partnership leverages the power of the Dyno platform ... and commercialization activities for multiple neurological gene therapy product candidates leveraging novel Dyno capsids. Roche ...
Summary. Being told you’re not strategic enough can be frustrating. If your strategy isn’t seen and understood, it’s as if it doesn’t exist at all. By making your strategy visible and easy ...
The move reflects the continuing influence and strategic decisions of the Ziff family within the company. For further insights into GB:TOWN stock, check out TipRanks’ Stock Analysis page.
As a platform built to solve the most critical challenges facing gene therapy developers, Dyno’s industry-leading gene delivery solutions enable Dyno partners to create ever better gene therapies.
New strategic partnership leverages the power ... and commercialization activities for multiple neurological gene therapy product candidates leveraging novel Dyno capsids. Roche will pay Dyno ...
Enterprise blockchain services provider R3 is looking for strategic options. It has been considering possibilities for at least the last six months, according to a report. R3 is the developer of ...